World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
74
Citations
28084
World Ranking
2030
National Ranking
76

Massimo Puoti publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Massimo Puoti sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 525 publications — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Massimo Puoti D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Massimo Puoti sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 74 D-Index — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Massimo Puoti is affiliated with the University of Milano-Bicocca in Italy. Their research predominantly spans the field of Medicine, with a particular focus on Infectious Diseases, Epidemiology, and Hepatology. Subfields they contribute to include Neurology and Virology, reflecting an interdisciplinary approach to medical research.

Their work covers key topics such as Hepatitis C virus research, Liver Disease Diagnosis and Treatment, Hepatitis B Virus Studies, and various aspects of COVID-19 clinical research. They have also addressed HIV/AIDS drug development and treatment.

Frequent coauthors collaborating with Massimo Puoti include:

  • Antonella d'Arminio Monforte
  • Marco Merli
  • Roberto Rossotti
  • Carlo Federico Perno
  • Annalisa Saracino

The venues in which Massimo Puoti publishes often include journals specializing in hepatology, infectious diseases, and antimicrobial chemotherapy, such as:

  • Journal of Hepatology
  • Digestive and Liver Disease
  • Liver International
  • Journal of Antimicrobial Chemotherapy
  • International Journal of Infectious Diseases

Representative recent scientific papers authored or coauthored by Massimo Puoti are:

  • EASL recommendations on treatment of hepatitis C: Final update of the series (2020), Journal of Hepatology
  • 2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0 (2020), HIV Medicine
  • Anti-NMDA receptor encephalitis in a psychiatric Covid-19 patient: A case report (2020), Brain Behavior and Immunity
  • Genomic epidemiology of SARS-CoV-2 reveals multiple lineages and early spread of SARS-CoV-2 infections in Lombardy, Italy (2021), Nature Communications
  • Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: A comparative analysis (2020), Journal of Infection

Best Publications

  • EASL Recommendations on Treatment of Hepatitis C

    Jean-Michel Pawlotsky;Alessio Aghemo;Geoffrey Dusheiko;Xavier Forns

  • Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

    Nezam Afdhal;Stefan Zeuzem;Paul Kwo;Mario Chojkier

  • Statements from the Taormina expert meeting on occult hepatitis B virus infection.

    Giovanni Raimondo;Jean Pierre Allain;Maurizia R. Brunetto;Marie Annick Buendia

  • EASL recommendations on treatment of hepatitis C: Final update of the series ☆

    Jean-Michel Pawlotsky;Francesco Negro;Alessio Aghemo;Marina Berenguer

  • A meta‐analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma

    Francesco Donato;Paolo Boffetta;Massimo Puoti

  • A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel.

    Markus Cornberg;Homie A. Razavi;Alfredo Alberti;Enos Bernasconi

  • Update of the statements on biology and clinical impact of occult hepatitis B virus infection

    Giovanni Raimondo;Stephen Locarnini;Teresa Pollicino;Massimo Levrero

  • Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection

    Stefan Zeuzem;Graham R Foster;Stanley Wang;Armen Asatryan

  • Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel.

    Vincent Soriano;Massimo Puoti;Mark Sulkowski;Antonietta Cargnel

  • Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel.

    Vincent Soriano;Mark Sulkowski;Colm Bergin;Angelos Hatzakis

  • Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

    Unknown

  • Selective depletion in HIV infection of T cells that bear specific T cell receptor V beta sequences.

    Luisa Imberti;Alessandra Sottini;Alessandra Bettinardi;Massimo Puoti

  • Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome.

    Puoti M;Bruno R;Soriano;Donato F

  • European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.

    JK Rockstroh;S Bhagani;Y Benhamou;R Bruno

  • Mortality for liver disease in patients with HIV infection: a cohort study.

    Massimo Puoti;Angiola Spinetti;Annibale Ghezzi;Francesco Donato

  • Natural history of chronic hepatitis B in co-infected patients

    Massimo Puoti;Carlo Torti;Raffaele Bruno;Gaetano Filice

  • Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects.

    Andrea De Luca;Roberto Bugarini;Alessandro Cozzi Lepri;Massimo Puoti

  • Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: a European collaborative study.

    Luz Martín-Carbonero;Yves Benhamou;Massimo Puoti;Juan Berenguer

  • Liver Fibrosis Progression Is Related to CD4 Cell Depletion in Patients Coinfected with Hepatitis C Virus and Human Immunodeficiency Virus

    Massimo Puoti;Maurizio Bonacini;Angiola Spinetti;Valeria Putzolu

  • Care of patients with hepatitis C and HIV co-infection.

    Vincent Soriano;Massimo Puoti;Mark Sulkowski;Stefan Mauss

  • Prophylaxis and treatment of hepatitis B in immunocompromised patients

    A Marzano;E Angelucci;P Andreone;M Brunetto

Frequent Co-Authors

Antonella d'Arminio Monforte
Antonella d'Arminio Monforte University of Milan
Giampiero Carosi
Giampiero Carosi University of Brescia
Antonio Craxì
Antonio Craxì University of Palermo
Carlo Federico Perno
Carlo Federico Perno University of Milan
Andrea Gori
Andrea Gori University of Milan
Andrea De Luca
Andrea De Luca University of Siena
Pietro Lampertico
Pietro Lampertico University of Milan
Andrea Antinori
Andrea Antinori Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani
Alessandro Cozzi-Lepri
Alessandro Cozzi-Lepri University College London
Giuliano Rizzardini
Giuliano Rizzardini ASST Fatebenefratelli Sacco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology opens doors to diverse healthcare careers, many of which can be further enhanced through specialized nursing and practitioner programs. For students interested in clinical roles, exploring easiest lpn programs to get into offers a practical starting point. These programs often provide flexible options for gaining foundational nursing skills.

For those aiming to advance their responsibilities, easy nurse practitioner programs to get into provide opportunities to obtain advanced certifications that complement an immunology background, facilitating roles in patient care and disease management.

Specializing further into mental health can also be a natural progression. Programs highlighted among the top online pmhnp programs ensure excellent clinical experiences, crucial for those looking to integrate immunological research with psychiatric care.

Affordability remains a key consideration for many students. Thankfully, options like the affordable pmhnp programs make advanced psychiatric nursing education accessible without compromising quality, supporting a range of career trajectories linked to immunology.

Best Scientists Citing Massimo Puoti

Trending Scientists

Recently Published Articles